Showing results (2011-2020 of 2,232) with videos related to

Sort By:
Pageof 224
Experimental Hematology & Oncology|November 11, 2021
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsLun-Xi Peng, Guang-Ling Jie, An-Na Li, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 12, 2015
Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome SequencingLu-Lu Yang, Xu-Chao Zhang, Shao-Kun Chuai, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2017
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screeningXu-Chao Zhang, Xu Cao, Chun Sun, et al.
Science Advances|April 6, 2019
Helicobacter pylori-induced matrix metallopeptidase-10 promotes gastric bacterial colonization and gastritisYi-Pin Lv, Ping Cheng, Jin-Yu Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)Ying Cheng, Tony S Mok, Xiangdong Zhou, et al.
Thoracic Cancer|April 19, 2022
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp- untreated patients with advanced non-small cell lung cancerKai-Cheng Peng, Jun-Wei Su, Zhi Xie, et al.
Lancet (London, England)|September 22, 2009
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyTudor Ciuleanu, Thomas Brodowicz, Christoph Zielinski, et al.
Iscience|October 9, 2023
Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinomaJia-Tao Zhang, Juan Zhang, Song-Rong Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 2019
Abrogation of cathepsin C by Helicobacter pylori impairs neutrophil activation to promote gastric infectionYu Gang Liu, Yong Sheng Teng, Ping Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2018
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung CancerYi-Long Wu, Li Zhang, Dong-Wan Kim, et al.
Pageof 224